Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation

Transplant Immunology

Volumn 20, Issue 1-2, 2008, Pages 95-98

  Sui, Weiguo ^a   Zou, Hequn ^b   Zou, Guimian ^a   Yan, Qiang ^a   Chen, Huaizhou ^a   Che, Wenti ^a   Xie, Shenping ^a  

^a No 181 Central Hospital   (China)

^b THE FIFTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

Insulin resistance; Kidney transplantation; Metabolic syndrome

Indexed keywords

ALBUMIN; CYCLOSPORIN A; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CALCULATION; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC GLOMERULONEPHRITIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG BLOOD LEVEL; DRUG DOSE REDUCTION; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INCIDENCE; INSULIN RESISTANCE; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; OBESITY; PATHOGENESIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RISK FACTOR; URINALYSIS;

ADULT; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; GLOMERULONEPHRITIS; HUMANS; INCIDENCE; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OVERWEIGHT; RISK FACTORS; TACROLIMUS;

EID: 56049100701     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2008.07.003     Document Type: Article

References (22)

1. Imig J.D. Eicosanoids and renal damage in cardiometabolic syndrome. Expert Opin Drug Metab Toxicol 4 2 (2008) 165-174
2. Druet C., Dabbas M., Baltakse V., Payen C., Jouret B., Baud C., et al. Insulin resistance and the metabolic syndrome in obese French children. Clin Endocrinol (Oxf) 64 6 (2006) 672-678
3. Zou H., Yao J., Wang Y.X., Wang J., Li D., and Wang P. Expression of matrix metalloproteinase-9 in renal tissues of rats with chronic allograft nephropathy at early stage and the role thereof. Chin Med J 85 14 (2005) 981-985
4. Zou H., Shi Y., Chen L., Zhou W., et al. Expression and role of matrix metalloproteinases/tissue inhibitors of metalloproteinases at the early stage of chronic allograft nephropathy (CAN). J Transplant Medicine 2 2 (2007) 81-90
5. Zou H., Wang G., Yao J., and Wang P. Expression and significance of MCP-1 and RANTES in renal tissue with chronic allograft nephropathy. J Transplant Medicine 2 3 (2007) 143-150
6. Zou H. Chronic allograft nephropathy. J Transplant Medicine 2 (2007) 32-40
7. de Vries A.P., Bakker S.J., van Son W.J., van der Heide J.J., Ploeg R.J., The H.T., et al. Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally. Am J Transplant 4 10 (2004) 1675-1683
8. Nigro J., Osman N., Dart A.M., and Little P.J. Insulin resistance and atherosclerosis. Endocr Rev 27 3 (2006) 242-259
9. Fam A.G. Gout, diet, and the insulin resistance syndrome. J Rheumatol 29 7 (2002) 1350-1355
10. Tan S., Hahn S., and Janssen O.E. Insulin resistance syndrome and polycystic ovary syndrome: implications for diagnosis and treatment. Panminerva Med 47 4 (2005) 211-217
11. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 7 (1985) 412-419
12. Coorperative meta-analysis group of China obesity task force. Predictive values of body mass index and waist circumference to risk factors of related diseases in Chinese adult population. Chin J Epidemiol 23 (2002) 5-10
13. Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. JAMA 285 19 (2001) 2486
14. Kershaw E.E., and Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89 6 (2004) 2548-2556
15. Dmitrewski J., Krentz A.J., Mayer A.D., Buckels J.A., Barnes A.D., Smith J., et al. Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation. Diabetes Obes Metab 3 4 (2001) 287-292
16. Boots J.M., van Duijnhoven E.M., Christiaans M.H., Wolffenbuttel B.H., and van Hooff J.P. Glucose metabolism in renal transplant recipients on tacrolimus: the effect of steroid withdrawal and tacrolimus trough level reduction. J Am Soc Nephrol 13 1 (2002) 221-227
17. Ginsberg H.N. Insulin resistance and cardiovascular disease. J Clin Invest 106 4 (2000) 453-458
18. Wang X.L., Zhang L., Youker K., Zhang M.X., Wang J., Scott A., et al. Free fatty acids inhibit insulin signaling-stimulated endothelial nitric oxide synthase activation through upregulating PTEN or inhibiting Akt kinase. Diabetes 55 8 (2006) 2301-2310
19. Busija D.W., Miller A.W., Katakam P., Simandle S., and Erdös B. Mechanisms of vascular dysfunction in insulin resistance. Curr Opin Investig Drugs 5 9 (2004) 929-935
20. Kincaid-Smith P. Hypothesis: obesity and the insulin resistance syndrome play a major role in end-stage renal failure attributed to hypertension and labelled hypertensive nephrosclerosis. J Hypertens 22 6 (2004) 1051-1055
21. Nosadini R., Manzato E., Solini A., Fioretto P., Brocco E., Zambon S., et al. Peripheral, rather than hepatic, insulin resistance and atherogenic lipoprotein phenotype predict cardiovascular complications in NIDDM. Eur J Clin Invest 24 4 (1994) 258-266
22. Ekstrand A.V., Groop P.H., and Grönhagen-Riska C. Insulin resistance precedes microalbuminuria in patients with insulin-dependent diabetes mellitus. Nephrol Dial Transplant 13 12 (1998) 3079-3083